Navigation Links
International Merchant Advisors to Develop Organic Science Branded Medical Marijuana Product Line
Date:4/25/2010

KINGWOOD, Texas, April 25 /PRNewswire-FirstCall/ -- International Merchant Advisors, Inc. (Pink Sheets: IMAI) www.imaiinc.com announced today that its wholly owned subsidiary, California based Organic Science, Inc., intends to launch a national line of medical marijuana products under the Organic Science brand name.  According to data provided in the new CNBC article "Marijuana and Money" www.cnbc.com, the medical marijuana national product market may be as large as $109 billion per year.

John Flinn, President of Organic Science, commented on the company's plans, "As the medical marijuana marketplace develops into a professional, nationwide business  model, we believe that consistent quality and a predictable branded product will be critical to the success of dispensaries serving this community.  Patients will want to depend on Organic Science products that give them the same predictable and effective result at an affordable price. We intend to develop the Organic Science brand as a national example of higher standards for the future growth of medical marijuana dispensaries and wellness centers throughout the USA in those states that medical marijuana is currently legal, such as California, Colorado, Montana, New Jersey, and others."

About International Merchant Advisors, Inc.

International Merchant Advisors, Inc. (IMAI) www.imaiinc.com is an international business banker and builder of companies focused on the development of Wellness Centers and Medical Marijuana clinics as a natural alternative for individuals suffering from chronic pain. IMAI intends to bring professional systems and controls to this highly fragmented mom and pop business, with medical supervision and legal compliance standards designed to raise the performance bar for those entering this highly regulated business segment. The company will acquire existing businesses, license and develop new clinics, and will act as an operations manager for non profit entities that dispense medical marijuana.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.


'/>"/>
SOURCE International Merchant Advisors, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 21, 2017 Cognitive Computing for Cancer ... allowing a previously unattainable level of personalized treatment ... ability, it is anticipated that the Global Cancer ... by 2022. The growth of the market is ... platforms, rising installation of cognitive computing software in ...
(Date:2/21/2017)... 2017 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the ... company will release its fourth quarter and full year ... February 28, 2017. The press release will be followed ... will be open to the public via telephone and ... its financial results and provide a business update. ...
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... For Immediate Release, Contact: ... leading provider of innovative software for connected home healthcare, today announced Orbita ... journey management for home healthcare. , Built on Orbita Health Cloud ...
(Date:2/20/2017)... , ... February 20, 2017 , ... The StayWell ... help health care providers better manage patient health risks, foster behavior change and improve ... library in the world, will present a demonstration of its video capability at StayWell ...
(Date:2/20/2017)... ... 2017 , ... Best Doctors® and IBM today announced that ... that want to help members of their workforce battling cancer. Through the Best ... suite of oncology offerings for insights on cancer treatment options, ranging from standard ...
(Date:2/20/2017)... ... 2017 , ... Johns Hopkins All Children's Hospital celebrated a major milestone with ... Friday marked the halfway point of construction and lifting of the final beam on ... as a center for innovation aimed at finding new discoveries and treatments for childhood ...
(Date:2/20/2017)... ... February 20, 2017 , ... Florida Hospital Pepin Heart ... ultrasound-enhanced thrombolysis machine, a state-of-the-art device that breaks up life-threatening blood clots by ... Family Foundation. , “We greatly appreciate this gift from Constellation Brands. We are ...
Breaking Medicine News(10 mins):